Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $45.4808 (-0.3%) ($45.0176 - $45.7419) on Mon. Jun. 16, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.67% (three month average) | RSI | 51 | Latest Price | $45.4808(-0.3%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -0.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) SPY(47%) VT(44%) XBI(41%) QQQ(40%) | Factors Impacting ABBV price | ABBV will decline at least -0.835% in a week (0% probabilities). VIXM(-25%) TLT(-15%) UUP(-7%) GLD(-5%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.835% (StdDev 1.67%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $45.59 | 5 Day Moving Average | $45.48(0%) | 10 Day Moving Average | $45.74(-0.57%) | 20 Day Moving Average | $45.59(-0.24%) | To recent high | -2.4% | To recent low | 16.2% | Market Cap | $80.241b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |